Literature DB >> 22040507

A historical view of alveolar echinococcosis, 160 years after the discovery of the first case in humans: part 1. What have we learnt on the distribution of the disease and on its parasitic agent?

Dominique Angèle Vuitton1, Qian Wang, Hong-Xia Zhou, Francis Raoul, Jenny Knapp, Solange Bresson-Hadni, Hao Wen, Patrick Giraudoux.   

Abstract

Since the first 2 cases observed in southern Germany and the correct identification of a parasite at the origin of the disease by the famous scientist Rudolf Virchow in 1855, the borders of the endemic area of alveolar echinococcosis (AE) have never stopped to expand. The parasite was successively recognized in Switzerland, then in Russia, Austria and France which were long considered as the only endemic areas for the disease. Cases were disclosed in Turkey in 1939; then much attention was paid to Alaska and to Hokkaido, in Japan. The situation totally changed in 1991 after the recognition of the Chinese endemic areas by the international community of scientists. The world map was completed in the beginning of the 21st century by the identification of AE in most of the countries of central/eastern Europe and Baltic States, and by the recognition of cases in central Asia. Up to now, the disease has however never been reported in the South hemisphere and in the United Kingdom. In the mid-1950s, demonstration by Rausch and Schiller in Alaska, and by Vogel in Germany, of the distinction between 2 parasite species responsible respectively for cystic echinococcosis (“hydatid disease”) and AE put an end to the long-lasting debate between the "dualists", who believed in that theory which eventually proved to be true, and the "unicists", who believed in a single species responsible for both diseases. At the end of the 20th century, molecular biology fully confirmed the "dualist" theory while adding several new species to the initially described E. granulosus; within the past decade, it also confirmed that little variation existed within Echinococcus (E.) multilocularis species, and that AE-looking infection in some intermediate animal hosts on the Tibetan plateau was indeed due to a new species, distinct from E. multilocularis, named E. shiquicus. Since the 1970s, the unique ecological interactions between the landscape, the hosts, and E. multilocularis have progressively been delineated. The important role of the rodent/lagomorph reservoir size for the maintenance of the parasite cycle has been recognized within the last 2 decades of the 20th century. And the discovery of a close relationship between high densities of small mammals and particularities in land use by agriculture/forestry has stressed the responsibility of political/economic decisions on the contamination pressure. Urbanization of foxes in Europe and Japan and the major role of dogs in China represent the new deals at the beginning of the 21st century regarding definitive hosts and prevention measures.

Entities:  

Mesh:

Year:  2011        PMID: 22040507

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  10 in total

1.  Exploration of common bile duct for treating hepatic cystic echinococcosis.

Authors:  Xing-Wen Liu; Ping Zhao; Li-Qun Gao; Jing Hu; Li-Ying Wang
Journal:  Int J Clin Exp Med       Date:  2015-01-15

2.  In vitro and in vivo activities of dicationic diguanidino compounds against Echinococcus multilocularis metacestodes.

Authors:  Tatiana Küster; Nadja Kriegel; David W Boykin; Chad E Stephens; Andrew Hemphill
Journal:  Antimicrob Agents Chemother       Date:  2013-05-28       Impact factor: 5.191

3.  International consensus on terminology to be used in the field of echinococcoses.

Authors:  Dominique A Vuitton; Donald P McManus; Michael T Rogan; Thomas Romig; Bruno Gottstein; Ariel Naidich; Tuerhongjiang Tuxun; Hao Wen; Antonio Menezes da Silva
Journal:  Parasite       Date:  2020-06-03       Impact factor: 3.000

4.  A Neglected Zoonosis in Albania: why Echinococcosis is Becoming a Surgeon's Exclusivity?

Authors:  Arben Pilaca; Gentian Vyshka; Arben Pepa; Kastriot Shytaj; Valentin Shtjefni; Arben Boçari; Arben Beqiri; Dhimitër Kraja
Journal:  Mediterr J Hematol Infect Dis       Date:  2014-02-16       Impact factor: 2.576

5.  Hepatic alveolar echinococcosis: Comparative computed tomography study between two Chinese and two European centres.

Authors:  Tilmann Graeter; Haihua Bao; Eric Delabrousse; Eleonore Brumpt; Rong Shi; Weixia Li; Yi Jiang; Julian Schmidberger; Wolfgang Kratzer; Wenya Liu
Journal:  Food Waterborne Parasitol       Date:  2020-05-11

6.  Efficacy of a novel topical combination of esafoxolaner, eprinomectin and praziquantel against Echinococcus multilocularis infections in cats.

Authors:  Joe Prullage; Dwight Bowman; Michael Ulrich; Eric Tielemans
Journal:  Parasite       Date:  2021-04-02       Impact factor: 3.000

7.  Populations at risk for alveolar echinococcosis, France.

Authors:  Martine Piarroux; Renaud Piarroux; Jenny Knapp; Karine Bardonnet; Jérôme Dumortier; Jérôme Watelet; Alain Gerard; Jean Beytout; Armand Abergel; Solange Bresson-Hadni; Jean Gaudart
Journal:  Emerg Infect Dis       Date:  2013-05       Impact factor: 6.883

8.  Difficulties in the diagnosis and management of alveolar hydatid disease: A case series.

Authors:  Ghodratollah Maddah; Abbas Abdollahi; Reza Sharifi-Nooghabi; Alireza Tavassoli; Mohammad Taghi Rajabi-Mashadi; Azadeh Jabbari-Nooghabi; Mehdi Jabbari-Nooghabi
Journal:  Caspian J Intern Med       Date:  2016

9.  Worldwide literature on epidemiology of human alveolar echinococcosis: a systematic review of research published in the twenty-first century.

Authors:  Sven Baumann; Rong Shi; Wenya Liu; Haihua Bao; Julian Schmidberger; Wolfgang Kratzer; Weixia Li
Journal:  Infection       Date:  2019-05-30       Impact factor: 3.553

10.  Human alveolar echinococcosis in Kyrgyzstan.

Authors:  Jumagul Usubalieva; Gulnara Minbaeva; Iskender Ziadinov; Peter Deplazes; Paul R Torgerson
Journal:  Emerg Infect Dis       Date:  2013-07       Impact factor: 6.883

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.